Monte Rosa Therapeutics, Inc. (GLUE)
18.81
-0.07
(-0.37%)
USD |
NASDAQ |
May 22, 16:00
18.80
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Total Liabilities (Quarterly) : 214.51M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 414.44M |
| Myriad Genetics, Inc. | 336.30M |
| BioRestorative Therapies, Inc. | 1.615M |
| Kyntra Bio, Inc. | 118.92M |
| Kura Oncology, Inc. | 544.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 736.43M |
| Shareholders Equity (Quarterly) | 521.92M |
| Debt to Equity Ratio | 0.0748 |
| Current Ratio | 9.538 |
| Net Debt Paydown Yield | 0.05% |